Genascence
VerifiedDeveloping revolutionized life changing gene therapies for prevalent musculoskeletal and joint diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$42—63m (Dealroom.co estimates May 2022.)
Palo Alto California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| investor investor investor investor | $0.0 | round | |
* | $11.6m | Grant | |
| Total Funding | 000k | ||